First Time Loading...

Rockwell Medical Inc
NASDAQ:RMTI

Watchlist Manager
Rockwell Medical Inc Logo
Rockwell Medical Inc
NASDAQ:RMTI
Watchlist
Price: 1.49 USD -2.61% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

RMTI doesn't have a meaningful market cap.

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. [ Read More ]

The intrinsic value of one RMTI stock under the Base Case scenario is 1.78 USD. Compared to the current market price of 1.49 USD, Rockwell Medical Inc is Undervalued by 16%.

Key Points:
RMTI Intrinsic Value
Base Case
1.78 USD
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Rockwell Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RMTI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Rockwell Medical Inc

Provide an overview of the primary business activities
of Rockwell Medical Inc.

What unique competitive advantages
does Rockwell Medical Inc hold over its rivals?

What risks and challenges
does Rockwell Medical Inc face in the near future?

Has there been any significant insider trading activity
in Rockwell Medical Inc recently?

Summarize the latest earnings call
of Rockwell Medical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Rockwell Medical Inc.

Provide P/S
for Rockwell Medical Inc.

Provide P/E
for Rockwell Medical Inc.

Provide P/OCF
for Rockwell Medical Inc.

Provide P/FCFE
for Rockwell Medical Inc.

Provide P/B
for Rockwell Medical Inc.

Provide EV/S
for Rockwell Medical Inc.

Provide EV/GP
for Rockwell Medical Inc.

Provide EV/EBITDA
for Rockwell Medical Inc.

Provide EV/EBIT
for Rockwell Medical Inc.

Provide EV/OCF
for Rockwell Medical Inc.

Provide EV/FCFF
for Rockwell Medical Inc.

Provide EV/IC
for Rockwell Medical Inc.

Show me price targets
for Rockwell Medical Inc made by professional analysts.

What are the Revenue projections
for Rockwell Medical Inc?

How accurate were the past Revenue estimates
for Rockwell Medical Inc?

What are the Net Income projections
for Rockwell Medical Inc?

How accurate were the past Net Income estimates
for Rockwell Medical Inc?

What are the EPS projections
for Rockwell Medical Inc?

How accurate were the past EPS estimates
for Rockwell Medical Inc?

What are the EBIT projections
for Rockwell Medical Inc?

How accurate were the past EBIT estimates
for Rockwell Medical Inc?

Compare the revenue forecasts
for Rockwell Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Rockwell Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Rockwell Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Rockwell Medical Inc compared to its peers.

Compare the P/E ratios
of Rockwell Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Rockwell Medical Inc with its peers.

Analyze the financial leverage
of Rockwell Medical Inc compared to its main competitors.

Show all profitability ratios
for Rockwell Medical Inc.

Provide ROE
for Rockwell Medical Inc.

Provide ROA
for Rockwell Medical Inc.

Provide ROIC
for Rockwell Medical Inc.

Provide ROCE
for Rockwell Medical Inc.

Provide Gross Margin
for Rockwell Medical Inc.

Provide Operating Margin
for Rockwell Medical Inc.

Provide Net Margin
for Rockwell Medical Inc.

Provide FCF Margin
for Rockwell Medical Inc.

Show all solvency ratios
for Rockwell Medical Inc.

Provide D/E Ratio
for Rockwell Medical Inc.

Provide D/A Ratio
for Rockwell Medical Inc.

Provide Interest Coverage Ratio
for Rockwell Medical Inc.

Provide Altman Z-Score Ratio
for Rockwell Medical Inc.

Provide Quick Ratio
for Rockwell Medical Inc.

Provide Current Ratio
for Rockwell Medical Inc.

Provide Cash Ratio
for Rockwell Medical Inc.

What is the historical Revenue growth
over the last 5 years for Rockwell Medical Inc?

What is the historical Net Income growth
over the last 5 years for Rockwell Medical Inc?

What is the current Free Cash Flow
of Rockwell Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Rockwell Medical Inc.

Financials

Balance Sheet Decomposition
Rockwell Medical Inc

Current Assets 28.2m
Cash & Short-Term Investments 11.7m
Receivables 9.4m
Other Current Assets 7.1m
Non-Current Assets 24.4m
PP&E 11.9m
Intangibles 11.8m
Other Non-Current Assets 705k
Current Liabilities 21.4m
Accounts Payable 3.9m
Accrued Liabilities 8.2m
Short-Term Debt 488k
Other Current Liabilities 8.8m
Non-Current Liabilities 9.7m
Long-Term Debt 5m
Other Non-Current Liabilities 4.7m
Efficiency

Earnings Waterfall
Rockwell Medical Inc

Revenue
80.8m USD
Cost of Revenue
-72.7m USD
Gross Profit
8.2m USD
Operating Expenses
-16.3m USD
Operating Income
-8.1m USD
Other Expenses
-1.2m USD
Net Income
-9.3m USD

Free Cash Flow Analysis
Rockwell Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

RMTI Profitability Score
Profitability Due Diligence

Rockwell Medical Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
24/100
Profitability
Score

Rockwell Medical Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

RMTI Solvency Score
Solvency Due Diligence

Rockwell Medical Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
39/100
Solvency
Score

Rockwell Medical Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RMTI Price Targets Summary
Rockwell Medical Inc

Wall Street analysts forecast RMTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMTI is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

Lowest
Price Target
5.05 USD
239% Upside
Average
Price Target
7.14 USD
379% Upside
Highest
Price Target
9.45 USD
534% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

RMTI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

RMTI Price
Rockwell Medical Inc

1M 1M
-8%
6M 6M
-7%
1Y 1Y
-32%
3Y 3Y
-87%
5Y 5Y
-97%
10Y 10Y
-99%
Annual Price Range
1.49
52w Low
1.23
52w High
6.19
Price Metrics
Average Annual Return -60.37%
Standard Deviation of Annual Returns 12.91%
Max Drawdown -99%
Shares Statistics
Market Capitalization 42.4m USD
Shares Outstanding 29 334 600
Percentage of Shares Shorted 2.31%

RMTI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Rockwell Medical Inc Logo
Rockwell Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

42.4m USD

Dividend Yield

0%

Description

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.

Contact

MICHIGAN
Wixom
30142 Wixom Road
+18004493353.0
https://www.rockwellmed.com/

IPO

1998-01-27

Employees

300

Officers

President, CEO & Director
Dr. Mark Strobeck Ph.D.
Executive VP, Chief Legal Officer & Secretary
Ms. Megan C. Timmins
Senior Vice President of Finance
Mr. Jesse Neri
Senior Vice President of Business & Corporate Development
Mr. James A. McCarthy
Senior Vice President of Sales & Marketing
Mr. Timothy T. Chole
Senior VP & Chief Corporate Affairs Officer
Ms. Heather R. Hunter
Show More
Secretary
Mr. David J. Kull
Investor Relations Representative
Mr. Jason Finkelstein
Show Less

See Also

Discover More
What is the Intrinsic Value of one RMTI stock?

The intrinsic value of one RMTI stock under the Base Case scenario is 1.78 USD.

Is RMTI stock undervalued or overvalued?

Compared to the current market price of 1.49 USD, Rockwell Medical Inc is Undervalued by 16%.